In a post-Congress conversation, web editor Nicole Raleigh spoke with Dr Corina Dutcus, senior vice president and oncology global clinical development lead at Eisai, who discussed the data and the ...

AMR demands sustained commitment beyond conventional market incentives. It requires founders with deep personal conviction ...

The outcome of the study was just one setback reported by Vertex as it updated investors on its second-quarter results, ...

Noom claims its microdose approach allows users to lose up to 11 pounds (around 5kg) in one month and up to 17 pounds in two ...

It's a pivotal moment for cell therapy. New trials, breakthrough data, major acquisitions and regulatory shifts are ...

The Gates Foundation is doubling down on its support for women's health research, pumping $2.5 billion between now and the ...

Around 240,000 people are expected to be offered Mounjaro over the next three years, according to NICE, which has recommended ...

Nalvee marks a return to the market for a dydrogesterone-only product after an absence of 17 years, and can be used in ...

Don't fall behind. Take a step toward becoming indispensable to your organization by attending our no-cost* LEAN Cell & Gene Boston Summit on Monday, September 22, conveniently planned just one day ...

Pharma 4.0 is no longer a future ambition; it’s the baseline. The ability to operate with real-time data, integrated systems, ...

At HLTH Europe, Deep Dive editor Eloise McLennan sat down with Scott Honken, chief commercial officer at WeightWatchers, to ...

Grant funding calls are often over-subscribed and success rates can be low. Excellent applications sometimes fail to be ...